The phrase NAD testing is incomplete until four things are named: the analyte, the sample it was measured in, the method that produced the signal, and the quantity the report states. The label NAD covers four related molecules, two oxidized and two reduced, and a method built to answer one question about them can be silent on another. This page teaches a research reader to extract those four items from a report, tell the main method families apart, and ask for the documentation a number needs.
Two document tasks are easy to confuse. One is an identity or content report on a research material: does a described lot contain the named compound, and in what proportion. The other measures NAD species inside an experimental matrix such as a cell or tissue extract. The compact NAD+ compound reference carries the identity introduction; this page owns assay targets, interference, sample conversion, and reporting.
Why read a NAD assay report from the analytical question, not the assay name?
An assay name describes a method family or a kit category, not the question a report answers. Before reading a result, write down the intended measurand, the quantity the procedure was meant to measure, and check that every later field refers to it. For NAD work the measurand is one of three things. Identity asks whether a named compound is present and matches a reference. Amount or concentration asks how much of a named species is present, on a stated basis. Ratio asks how two named species compare within one sample. A method can deliver one without the others: a chromatographic peak at the expected position supports identity but says nothing about amount until a calibration exists, and two amounts support a ratio only when both share a basis.
NAD testing is not one task. A usable report names the exact analyte, meaning which of the four NAD species was measured, the matrix the sample came from, the method that produced the signal, and the reported quantity: identity, amount, concentration, or ratio. Two reports can both say NAD assay and answer different questions.
| Task | Object measured | Question answered | Reading guidance |
|---|---|---|---|
| Material identity or content report | A described lot, such as <supplier-lot> | Is the named compound present, and in what proportion | The certificate reading guide and the quality documentation directory |
| Species measurement in a research matrix | NAD species in a cell or tissue extract | How much of each named species was present at sampling, and in what ratio | This page |
A teaching example: a header reads NAD assay, sample <supplier-lot>, result pass. It does not state which species was targeted, whether the sample was the material or an extract of it, what the signal was compared against, or what pass means. The catalog specification for a listed material describes a listing, not an assay result.
What is the difference between NAD+, NADH, NADP+, and NADPH on a report?
Four names cover two chemical pairs, and a report has to say which member of which pair it measured. NAD+ is the oxidized form of nicotinamide adenine dinucleotide, as its ChEBI record states. NADH is the reduced counterpart; its record describes two nucleotides joined through phosphate groups, one containing adenine and the other nicotinamide. NADP+ has a separate ChEBI record as a phosphorylated species, so it is not another way of writing NAD+, and NADPH is the reduced form of NADP+. Because the four have separate records and structures, the shorthand NAD(P)(H) is a family label, not one analyte. Reference entries also distinguish conjugate acid and base forms, so the plus sign in the everyday name does not describe every protonation state. An identity record describes a molecule, not a sample measurement or a certificate.
NAD+ and NADH form one oxidized and reduced pair; NADP+ and NADPH form a second pair distinguished by an additional phosphate group. Each has its own chemical identity record. A report must identify which single species, or which explicitly listed combination, was measured. A result labelled NAD, NAD(P)H, or total NAD is undefined until the included forms are written out.
| Name | ChEBI record | Pair and state | What a report must specify |
|---|---|---|---|
| NAD+ | CHEBI:15846 | NAD pair, oxidized | Whether NADH was measured separately, summed in, or excluded |
| NADH | CHEBI:16908 | NAD pair, reduced | That the reduced form was preserved to measurement and calibrated as itself |
| NADP+ | CHEBI:18009 | NADP pair, oxidized | How the method tells it apart from NAD+ |
| NADPH | CHEBI:16474 | NADP pair, reduced | Both the preservation and the phosphate discrimination points |
label could cover ------------ ---------------------------------------------- NAD+ one species: oxidized, no extra phosphate NADH one species: reduced, no extra phosphate NAD NAD+ alone, or NAD+ and NADH summed: unclear NAD/NADH both species, as one ratio or as two values NAD(P)H NADH, NADPH, or both NAD(P)(H) any of the four total NAD undefined until the summed forms are listed
What do liquid chromatography and mass spectrometry each contribute to a NAD assay?
Liquid chromatography coupled to mass spectrometry, written LC-MS, is two analytical layers in sequence, and a report should describe each. The chromatography layer separates the components of a liquid extract in time: species travel through a column at different rates and reach the detector at different retention times. The mass spectrometry layer then detects ions by their mass-to-charge ratio, a mass-selective filter. Separation resolves species that would otherwise overlap; mass detection checks that the signal at a given time has the expected mass. Neither layer alone settles every identity question: two species of identical mass that separate poorly can be confused, and a mass match without a retention time match is weaker than both together. An instrument name does not guarantee specificity; the documented combination of separation, mass detection, reference standards, and calibration does.
A bounded primary example: Lu and colleagues, in a study published online in 2017 and issued in 2018, compared seven extraction and quenching solvent systems in cultured mammalian cells and mouse tissues, analysed the extracts by LC-MS, and considered NAD+, NADH, NADP+, and NADPH as separate analytes. Only the abstract was read for this page; the solvent systems are not reproduced, and conditions that worked in those samples do not establish performance elsewhere.
| Layer | Contributes | Report fields that describe it | Cannot establish alone |
|---|---|---|---|
| Extraction, before chromatography | An extract the instrument can accept; where forms can interconvert | Quench and extraction description, recovery, interconversion controls | Anything about the original sample, if conversion was not monitored |
| Liquid chromatography | Separation in time | Column category, retention time of each analyte and its reference standard, resolution between peaks | Identity, since unrelated species can share a retention time |
| Mass spectrometry | Mass-selective detection | Ions or transitions monitored, mass accuracy or resolution category, internal standard, peak assignment rule | Amount, until a calibration model links signal to quantity |
How does an enzyme-cycling assay generate a measurable NAD signal?
An enzyme-cycling assay does not observe the analyte directly. It couples the analyte to a chemical and enzyme system that repeatedly oxidizes and reduces it, and each turn of the cycle produces a detectable product, read as color, fluorescence, or luminescence. Because the product accumulates over many cycles, a small amount of analyte can give a large signal. The signal is a function of the analyte-dependent reaction, so two things must be documented before it becomes a quantity. The first is a calibration model, which in ICH Q2(R2) vocabulary relates measured signals from known samples to the property of interest. The second is selectivity, which concerns interference from other components of the mixture or matrix. Any species the enzyme system accepts as a substrate contributes to the signal, and the readout cannot tell the contributions apart.
A cycling-assay signal depends on which substrates the enzyme system accepts and on the calibration that converts signal to quantity. Because any accepted substrate adds to the readout, a result cannot be attributed to NAD+ alone unless selectivity against related species has been documented for that assay in that matrix. An assay name, however familiar, does not by itself prove exclusive NAD measurement.
A 2024 paper by Cirilli and colleagues illustrates the point. The authors adapted an enzyme-cycling NAD/NADH assay to measure a different biochemical reaction, the base-exchange activity of an enzyme, and reported that the NAD analogue 3-acetylpyridine adenine dinucleotide also serves as a substrate in that assay and generates an amplified signal. Their target was enzyme activity, not the NAD content of a research material, and their result describes one assay system, not every NAD assay.
| Point | LC-MS | Enzyme cycling |
|---|---|---|
| Analytical principle | Time separation, then mass-selective detection of ions | Repeated enzymatic oxidation and reduction, with an accumulating product read as signal |
| Documentation needed | Extraction and quench record, retention times against standards, ions monitored, internal standards, calibration model | Enzyme system and detection product, calibrator identity, selectivity data against sibling species and analogues, calibration model |
| Interpretive failure | Identity from mass alone; a ratio without interconversion controls | Whole signal attributed to one species; signal read as quantity without calibration |
Why can sample handling change a reported NAD+/NADH ratio?
A reported NAD+/NADH ratio is a claim about the state of a sample at the moment it was taken. Between that moment and the detector, the oxidized and reduced forms can convert into each other, and either can degrade, so the numbers in the report may describe the extract rather than the original sample. The extraction study by Lu and colleagues identified interconversion during extraction as a major problem for redox-ratio measurement and acid-catalysed degradation as a separate concern; different extraction systems produced different interconversion and recovery behaviour. Quenching means stopping reactions at sampling so that later steps do not alter the species present. Isotope controls mean using labelled material so that a species formed during preparation can be told apart from one present originally; that study used isotope-labelled cells with added unlabelled standards.
Sample preparation can change oxidized and reduced NAD species into one another and can degrade them, so a ratio measured after extraction may not equal the ratio in the original sample. A reported NAD+/NADH value is interpretable only alongside the record of how conversion was prevented or monitored. The sample-preparation description is part of the result, not background to it.
Artifact and original are two different worksheet columns: a ratio stated without a quench description, a recovery assessment, and some form of conversion monitoring is a number about an extract, not the sample, and comparing it with a monitored ratio compares two different questions.
What calibration and performance evidence should a NAD report include?
The ICH Q2(R2) guideline on validation of analytical procedures supplies the performance vocabulary used here. Validation evaluates whether a procedure suits its intended purpose. Accuracy concerns agreement with an accepted reference value. Precision concerns scatter across repeat measurements, with repeatability, intermediate precision, and reproducibility as its three scopes. Detection can be established below the level at which quantitative accuracy and precision are suitable. The reportable range is the interval over which results have appropriate accuracy and precision. Selectivity concerns interference from other components of a mixture or matrix. A calibration model relates signals from known samples to the property of interest. Robustness examines the effect of deliberate variation of parameters. The guideline is cited for vocabulary only; nothing here claims it applies to, certifies, or was followed by any material, kit, or lot.
| Term | Meaning in the guideline | Question for a NAD report |
|---|---|---|
| Accuracy | Agreement with an accepted reference value | Against which reference, for which species? |
| Precision and its scopes | Scatter among repeat measurements, in three scopes: repeatability, intermediate precision, reproducibility | Is scatter stated, and which scope does it cover? |
| Detection | Establishable below the level suitable for quantitation | Is the result a detection or a quantity? |
| Reportable range | Interval with appropriate accuracy and precision | Does the value fall inside a stated range? |
| Selectivity | Freedom from interference by other components | Were sibling species and plausible analogues tested? |
| Calibration model | Relationship between known-sample signals and the property | What calibrator, and how was signal converted? |
| Robustness | Effect of deliberate parameter variation | Were parameters varied, and did the result hold? |
| Reference material | Needs suitable characterization, homogeneity, and stability | How were the calibrator's identity and stability established? |
For NAD, selectivity has two obvious targets: the sibling species within each pair, and for cycling assays the analogues the enzyme system may accept. A calibrator whose identity is assumed transfers that assumption into every result built on it.
How do concentration, amount, ratio, and normalized NAD values differ?
Four kinds of number appear in NAD reports, and each needs different supporting fields. An amount is a quantity of substance in a defined sample or extract, in a unit of mass or moles. A concentration is an amount divided by a denominator such as extract volume, sample mass, protein content, or cell number; without the denominator it is not a concentration. A total, such as total NAD, needs a definition of which species were summed. A ratio needs its numerator and denominator identified, obtained on a comparable basis, and preserved under the same conditions. A normalized value needs the normalizer named and its own measurement stated, since a value per cell and a value per unit of protein are not interchangeable.
The ratio case is easiest to state symbolically. Let a be the reported NAD+ amount and b the reported NADH amount from the same extract. Then reported NAD+/NADH = a divided by b, meaningful only when a and b share the same sample, preparation, and unit. Swapping numerator and denominator gives b divided by a, the inverse question, so reports that orient the ratio differently cannot be compared by their numbers alone. No values are given here on purpose.
reported quantity must state incomplete if it only says ------------------ --------------------------------------- -------------------------- amount unit; which sample or extract NAD+: <value> concentration amount unit AND the denominator NAD+: <value> per sample total NAD which species are summed total NAD: <value> ratio numerator, denominator, shared basis NAD+/NADH: <value> normalized value the normalizer and how it was measured <value> per cell
Content reports on a material use a different basis, typically a fraction of the material rather than an amount in an extract; reading those fields belongs to the certificate reading guide. A content fraction and an extract concentration are sometimes both called a NAD level and are not the same quantity.
A practical assay-document comparison worksheet
The worksheet below turns the preceding sections into ten fields and three outcome states. It is filled in from what a report says, and every field accepts the entry not stated. The outcome states are: documented and comparable, meaning the field is stated and answers the same question as the report it is compared with; documented but a different question, meaning the field is stated but addresses another analyte, basis, or endpoint; and unresolved, meaning the field is absent or ambiguous. An analytical endpoint is what was measured, such as NAD+ amount in an extract. A performance claim is how well it was measured, such as a stated precision. A report can name its endpoint clearly and make no performance claim, and the worksheet records the two separately.
Two hypothetical descriptions fill the example columns. They are teaching constructs, not laboratory results, and describe no real supplier, material, or lot. Report A names one analyte, NAD+, and one matrix, a cell extract, but says nothing about calibration. Report B states an aggregate NAD result without saying which forms are included.
| Field | What to record | Report A, hypothetical | Report B, hypothetical |
|---|---|---|---|
| Analyte | Exact species or listed combination | NAD+: documented | Aggregate NAD, forms unlisted: unresolved |
| Sample identity and matrix | Material lot or extract, and of what | Cell extract: documented | Not stated: unresolved |
| Assay principle | LC-MS, enzyme cycling, or another named principle | Not stated: unresolved | Enzyme cycling: documented |
| Conversion controls | Quench, recovery, interconversion monitoring | Not stated: unresolved | Not stated: unresolved |
| Calibration reference | Calibrator identity; how signal became quantity | Not stated: unresolved | Not stated: unresolved |
| Selectivity | Evidence against sibling species and analogues | Not stated: unresolved | Not stated: unresolved |
| Unit and normalization | Unit, denominator, normalizer | Per cell: documented | Undefined until the analyte is: unresolved |
| Range and limits | Reportable range; detection versus quantitation | Not stated: unresolved | Not stated: unresolved |
| Repeatability | Stated scatter and its scope | Not stated: unresolved | Not stated: unresolved |
| Unresolved questions | Every field marked unresolved | Six fields | Eight fields |
Report A is documented on analyte, matrix, and unit, and unresolved on calibration, range, and repeatability: an endpoint without a performance claim. Report B is unresolved on analyte, which makes its unit and any ratio unresolvable too. They are missing different information; neither is shown to be better, and their numbers cannot be compared until both answer the same question.
Frequently asked questions
Does an NAD/NADH assay necessarily report NAD+ alone?
No. The name describes a method family, usually an enzyme-cycling system, not the species that ended up in the number. Such an assay may report NAD+ alone, NADH alone, both separately, their sum, or their ratio, depending on sample preparation and calibrator. A published adaptation of one cycling assay showed that an NAD analogue also produced signal in it. Read which species the method was calibrated for and which related species were tested for interference before deciding what the number covers.
Is NADP+ interchangeable with NAD+ in an assay description?
No. NADP+ carries an additional phosphate group and has its own chemical identity record, separate from the record for NAD+. A method description that names NAD+ as the analyte has made no statement about NADP+, and a method that responds to both has to say so. A bracketed shorthand such as NAD(P)+ names a family rather than one analyte, so ask which of the two was calibrated, which was measured, and whether the method can tell them apart.
Why can sample preparation change a measured NAD+/NADH ratio?
Because the oxidized and reduced forms can convert into one another, and can degrade, between sampling and measurement. A published extraction study in cultured cells and mouse tissues identified this interconversion during extraction as a major problem for redox-ratio measurement and acid-catalysed degradation as a separate concern, and different extraction systems behaved differently. A ratio therefore describes the extract unless the report shows how reactions were stopped at sampling and how conversion during preparation was monitored, for example with isotope-labelled material.
What is the difference between detecting an analyte and quantifying it?
Detection establishes that the analyte produced a signal distinguishable from background; in ICH Q2(R2) vocabulary it can be established below the level at which quantitative accuracy and precision are suitable. Quantitation establishes how much analyte is present, which requires a calibration model relating signal to quantity, a reportable range inside which the result falls, and evidence of accuracy and precision at that level. A peak at the expected mass is a detection; a number with a unit, a range, and a calibrator is a quantity.
Does a result from an experimental sample verify the contents of a supplier's material lot?
No. A measurement of NAD species in a cell or tissue extract describes that extract under that preparation. It says nothing about what a container of research material held before the experiment, because the sample, matrix, controls, and question all differ. Verifying a lot's contents is an identity and content question answered by documentation for that specific lot, such as a certificate matched to the lot reference on the label; the certificate reading guide and quality documentation directory cover that. The NAD+ testing and assay methods reference states no result for any lot.
Sources and scope notes
Sources and dates. Analyte identities come from the ChEBI records for NAD+, NADH, NADP+, and NADPH, last modified July 26, 2019 for the first three and July 15, 2020 for NADPH. The extraction study by Lu and colleagues appeared online July 19, 2017 and in a 2018 issue; the cycling-assay paper by Cirilli and colleagues was published February 14, 2024. ICH Q2(R2) was adopted November 1, 2023 and corrected November 30, 2023. All were read September 20, 2026, Pacific time.
Evidence boundaries. Only the abstracts of the two primary studies were read; full protocols, supplementary files, and complete limitation statements were not checked, and the extraction study's full text was not retrievable. That study is bounded by its own samples, cultured mammalian cells and mouse tissues; the cycling-assay paper describes one assay system and one analogue. ICH Q2(R2) is a pharmaceutical-registration document cited for vocabulary only.
Out of scope. Current kit inventory, the contents of any product lot, any supplier's test methods, and physiological reference values were not inspected and are not described. This page is not a personal test guide, a reference-range guide, a kit recommendation, a dietary-source article, or an experiment protocol, and it does not infer that any assay kit is supplied through this site.
- ChEBI CHEBI:15846, NAD+ Last modified July 26, 2019.
- ChEBI CHEBI:16908, NADH Last modified July 26, 2019.
- ChEBI CHEBI:18009, NADP+ Last modified July 26, 2019.
- ChEBI CHEBI:16474, NADPH Last modified July 15, 2020.
- Lu et al., Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors Online July 19, 2017; 2018 issue; DOI 10.1089/ars.2017.7014. Abstract only.
- Same study, Europe PMC record and abstract Mirror record; full text not retrievable.
- Cirilli et al., 2024, adaptation of an enzyme-cycling NAD/NADH assay February 14, 2024; DOI 10.3390/molecules29040847. Abstract only.
- Same paper, PubMed Central record Not independent evidence; no full-text-only fact is used.
- ICH Q2(R2), Validation of Analytical Procedures: introduction and glossary Adopted November 1, 2023, corrected November 30, 2023. Vocabulary only.